Emeren Group Ltd. Sponsored ADR (SOL)
(Delayed Data from NYSE)
$1.69 USD
+0.10 (6.29%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.69 0.00 (0.00%) 6:46 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Income Statements
Fiscal Year end for Emeren Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 105 | 61 | 80 | 74 | 119 |
Cost Of Goods | NA | 46 | 48 | 57 | 85 |
Gross Profit | NA | 15 | 31 | 17 | 34 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 18 | 19 | 10 | 35 |
Income After Depreciation & Amortization | 0 | -3 | 13 | 7 | -1 |
Non-Operating Income | NA | 3 | 0 | 2 | 0 |
Interest Expense | NA | 3 | 5 | 6 | 9 |
Pretax Income | NA | -3 | 7 | 2 | -11 |
Income Taxes | NA | 2 | 1 | 0 | 1 |
Minority Interest | NA | 0 | 0 | -1 | -3 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -5 | 7 | 2 | -12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -5 | 7 | 3 | -9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 4 | 19 | 14 | 7 |
Depreciation & Amortization (Cash Flow) | NA | 7 | 7 | 7 | 8 |
Income After Depreciation & Amortization | 0 | -3 | 13 | 7 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.53 | 65.47 | 69.50 | 49.79 | 40.60 |
Diluted EPS Before Non-Recurring Items | 0.02 | 0.06 | 0.17 | 0.09 | 0.35 |
Diluted Net EPS (GAAP) | -0.16 | -0.07 | 0.10 | 0.06 | -0.22 |
Fiscal Year end for Emeren Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 44.00 | 13.95 | 33.85 | 12.88 |
Cost Of Goods | NA | NA | 8.26 | 21.18 | 11.28 |
Gross Profit | NA | NA | 5.69 | 12.66 | 1.59 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 9.64 | 7.62 | 4.60 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -3.95 | 5.04 | -3.01 |
Non-Operating Income | NA | NA | -4.73 | 2.22 | 2.79 |
Interest Expense | NA | NA | 0.08 | -0.38 | 0.13 |
Pretax Income | NA | NA | -8.77 | 7.65 | -0.35 |
Income Taxes | NA | NA | 0.25 | -0.04 | 0.26 |
Minority Interest | NA | NA | 0.37 | -0.67 | -0.42 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -8.09 | -9.02 | 7.68 | -0.62 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -8.09 | -9.39 | 8.35 | -0.19 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 55.20 | 56.29 | 57.23 | 57.41 |
Diluted EPS Before Non-Recurring Items | NA | -0.15 | 0.01 | 0.14 | 0.00 |
Diluted Net EPS (GAAP) | NA | -0.15 | -0.17 | 0.14 | 0.00 |